- Home
- LNKB vs QTRX Comparison
LNKB vs QTRX Comparison
Compare LNKB & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- QTRX
- Stock Information
- Founded
- LNKB 2018
- QTRX 2007
- Country
- LNKB United States
- QTRX United States
- Employees
- LNKB N/A
- QTRX N/A
- Industry
- LNKB
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- LNKB
- QTRX Industrials
- Exchange
- LNKB Nasdaq
- QTRX Nasdaq
- Market Cap
- LNKB 261.4M
- QTRX 241.2M
- IPO Year
- LNKB N/A
- QTRX 2017
- Fundamental
- Price
- LNKB $6.96
- QTRX $5.07
- Analyst Decision
- LNKB Strong Buy
- QTRX Hold
- Analyst Count
- LNKB 1
- QTRX 4
- Target Price
- LNKB $9.00
- QTRX $11.75
- AVG Volume (30 Days)
- LNKB 110.7K
- QTRX 493.5K
- Earning Date
- LNKB 10-27-2025
- QTRX 11-06-2025
- Dividend Yield
- LNKB 4.29%
- QTRX N/A
- EPS Growth
- LNKB 512.12
- QTRX N/A
- EPS
- LNKB 1.03
- QTRX N/A
- Revenue
- LNKB $122,594,000.00
- QTRX $125,784,000.00
- Revenue This Year
- LNKB $18.26
- QTRX N/A
- Revenue Next Year
- LNKB N/A
- QTRX $37.89
- P/E Ratio
- LNKB $6.78
- QTRX N/A
- Revenue Growth
- LNKB 42.32
- QTRX N/A
- 52 Week Low
- LNKB $6.09
- QTRX $4.05
- 52 Week High
- LNKB $7.98
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- LNKB 43.70
- QTRX 37.33
- Support Level
- LNKB $6.85
- QTRX $5.68
- Resistance Level
- LNKB $7.10
- QTRX $5.99
- Average True Range (ATR)
- LNKB 0.19
- QTRX 0.29
- MACD
- LNKB -0.01
- QTRX -0.13
- Stochastic Oscillator
- LNKB 11.32
- QTRX 7.17
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.